Doctor of Osteopathy Program year 2020 Reported 2019–2020 Source: CMS Open Payments, 2026 publication

Karsten Johnson

Dermatology Salem, OR Doctor of Osteopathy

NPI 1154700839 CMS profile 1355156

1793 13Th St Se, Salem, OR 97302

Open in the dashboard

General payments

$10,591

155 records reported · program years 2019–2020

Research payments

$0

Paid to them · None reported · program years 2019–2020

Ownership & investment interest

$0

None reported

Through program year 2020, Karsten Johnson of Salem, OR is reported in the CMS Open Payments database as having received $10,591 across 155 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 81st percentile of Dermatology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

2 rows
Year Kind Relative to this record's peak year Amount Records
2020 General $6,949 51
2019 General $3,642 104

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Karsten Johnson
  • Dermatology median
  • Middle half of Dermatology
  • National median

In program year 2025, general payments to Karsten Johnson were reported at $0. Among 10,363 Dermatology profiles paid that year, the median was $788 and the middle half received between $207 and $1,974.

Show as a table
Year Karsten Johnson Dermatology median Middle half National median
2019 $3,642 $454 $129–$1,240 $163
2020 $6,949 $235 $81–$756 $114
2021 $0 $377 $108–$1,108 $132
2022 $0 $514 $143–$1,391 $149
2023 $0 $607 $159–$1,674 $160
2024 $0 $751 $204–$1,903 $164
2025 $0 $788 $207–$1,974 $169

Breakdown

Who paid General payments · program years 2019–2020
  1. Amgen Inc. $5,297 14 payments
  2. AbbVie, Inc. $1,714 35 payments
  3. Novartis Pharmaceuticals Corporation $1,505 35 payments
  4. Celgene Corporation $606 9 payments
  5. Ortho Dermatologics, a division of Bausch Health US, LLC $289 9 payments
  6. Lilly USA, LLC $235 18 payments
  7. Janssen Biotech, Inc. $164 6 payments
  8. Sun Pharmaceutical Industries Inc. $141 6 payments
  9. UCB, Inc. $128 3 payments
  10. Almirall LLC $119 1 payment
  11. Other $393 19 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2020
  1. Food and Beverage $5,158 146 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $4,600 4 payments
  3. Travel and Lodging $764 4 payments
  4. Education $70 1 payment
Products named General payments · program years 2019–2020
  1. Otezla Inflammation $5,277 11 payments
  2. SKYRIZI $1,139 23 payments
  3. COSENTYX Dermatology $1,036 27 payments
  4. HUMIRA $759 24 payments
  5. Otezla Dermatology $525 2 payments
  6. COSENTYX Immunology $344 7 payments
  7. TALTZ $235 18 payments
  8. DUOBRII $161 5 payments
  9. ILUMYA $141 6 payments
  10. TREMFYA $133 4 payments
  11. Other $1,040 51 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

155 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Dermatology in Oregon

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2020

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record